A. Gulbenkian

759 total citations
23 papers, 599 citations indexed

About

A. Gulbenkian is a scholar working on Physiology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, A. Gulbenkian has authored 23 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 9 papers in Molecular Biology and 6 papers in Immunology and Allergy. Recurrent topics in A. Gulbenkian's work include Asthma and respiratory diseases (7 papers), Allergic Rhinitis and Sensitization (5 papers) and Metabolism and Genetic Disorders (3 papers). A. Gulbenkian is often cited by papers focused on Asthma and respiratory diseases (7 papers), Allergic Rhinitis and Sensitization (5 papers) and Metabolism and Genetic Disorders (3 papers). A. Gulbenkian collaborates with scholars based in United States and United Kingdom. A. Gulbenkian's co-authors include I.I.A. Tabachnick, William Kreutner, FLOYD SEIDMAN, Richard W. Chapman, S. Tozzi, Marvín I. Siegel, Robert W. Egan, Arthur S. Watnick, Xiomara Fernandez and Louis C. Iorio and has published in prestigious journals such as Nature, Diabetes and Endocrinology.

In The Last Decade

A. Gulbenkian

23 papers receiving 508 citations

Peers

A. Gulbenkian
Stephen M. Spaethe United States
Stephen L. Underwood United Kingdom
F. Hahn Germany
H. Giertz Germany
Cheng-Po Sung United States
Harry Sacks United States
S K Young United States
Stephen M. Spaethe United States
A. Gulbenkian
Citations per year, relative to A. Gulbenkian A. Gulbenkian (= 1×) peers Stephen M. Spaethe

Countries citing papers authored by A. Gulbenkian

Since Specialization
Citations

This map shows the geographic impact of A. Gulbenkian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Gulbenkian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Gulbenkian more than expected).

Fields of papers citing papers by A. Gulbenkian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Gulbenkian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Gulbenkian. The network helps show where A. Gulbenkian may publish in the future.

Co-authorship network of co-authors of A. Gulbenkian

This figure shows the co-authorship network connecting the top 25 collaborators of A. Gulbenkian. A scholar is included among the top collaborators of A. Gulbenkian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Gulbenkian. A. Gulbenkian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barnett, A, Louis C. Iorio, William Kreutner, et al.. (1994). Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine. Inflammation Research. 43(3-4). 149–157. 2 indexed citations
2.
Gulbenkian, A., Robert W. Egan, Xiomara Fernandez, et al.. (1992). Interleukin-5 Modulates Eosinophil Accumulation in Allergic Guinea Pig Lung. American Review of Respiratory Disease. 146(1). 263–265. 112 indexed citations
3.
Gulbenkian, A., Robert W. Egan, Xiomara Fernandez, et al.. (1991). 265 IL-5 modulates eosinophil accumulation in allergic guinea pig lung. Journal of Allergy and Clinical Immunology. 87(1). 206–206. 6 indexed citations
4.
Gulbenkian, A., Xiomara Fernandez, William Kreutner, et al.. (1990). Anaphylactic Challenge Causes Eosinophil Accumulation in Bronchoalveolar Lavage Fluid of Guinea Pigs: Modulation by Betamethasone, Phenidone, Indomethacin, WEB 2086, and a Novel Antiallergy Agent, SCH 37224. American Review of Respiratory Disease. 142(3). 680–685. 44 indexed citations
5.
Gulbenkian, A., Jason W. Myers, Robert W. Egan, & Marvín I. Siegel. (1987). The role of a Ca2+/calmodulin dependent plasma membrane Ca2+ channel during Concanavalin A activation of MC9 mast cells. Inflammation Research. 22(1-2). 16–23. 4 indexed citations
6.
Kreutner, William, Richard W. Chapman, A. Gulbenkian, & Marvín I. Siegel. (1987). Antiallergic activity of loratadine, a non‐sedating antihistamine. Allergy. 42(1). 57–63. 74 indexed citations
7.
Kreutner, William, Richard W. Chapman, A. Gulbenkian, & S. Tozzi. (1985). Bronchodilator and antiallergy activity of forskolin. European Journal of Pharmacology. 111(1). 1–8. 23 indexed citations
9.
Gulbenkian, A., et al.. (1980). Hamster Flank Organ Hydrolase and Lipase Activity. Journal of Investigative Dermatology. 75(4). 289–292. 7 indexed citations
10.
Gulbenkian, A., L. S. Ornstein, & I.I.A. Tabachnick. (1972). The Use of Diazoxide Inhibition of Insulin Secretion as a Tool to Investigate Insulin Stimulation by Other Agents. Hormone and Metabolic Research. 4(2). 57–58. 4 indexed citations
11.
Kreutner, William, A. Gulbenkian, & I.I.A. Tabachnick. (1970). Effect of epinephrine on hepatic glycogen phosphorylase and synthetase activities in normal and pertussis-sensitized rats. Biochemical Pharmacology. 19(9). 2561–2567. 7 indexed citations
12.
Gulbenkian, A., et al.. (1969). Adrenergic changes due to pertussis: Insulin, glucose and free fatty acids. European Journal of Pharmacology. 7(2). 186–195. 10 indexed citations
13.
Gulbenkian, A., et al.. (1969). Effects in vivo and in vitro of nonsteroidal anti-inflammatory drugs on (rat stomach) histidine decarboxylase. Biochemical Pharmacology. 18(7). 1784–1788. 10 indexed citations
14.
Gulbenkian, A., et al.. (1968). Metabolic Effects of Pertussis Sensitization in Mice and Rats. Endocrinology. 83(4). 885–892. 41 indexed citations
15.
Tabachnick, I.I.A. & A. Gulbenkian. (1968). MECHANISM OF DIAZOXIDE HYPERGLYCEMIA IN ANIMALS. Annals of the New York Academy of Sciences. 150(2). 204–218. 24 indexed citations
16.
Gulbenkian, A., et al.. (1967). The effect of altered carbohydrate metabolism in pertussis-sensitized mice on anaphylaxis. Biochemical Pharmacology. 16(5). 783–792. 8 indexed citations
17.
Tabachnick, I.I.A., et al.. (1965). The hyperglycemic activity of benzothiadiazine and other diuretics. Life Sciences. 4(20). 1931–1936. 11 indexed citations
18.
Tabachnick, I.I.A., A. Gulbenkian, & FLOYD SEIDMAN. (1965). FURTHER STUDIES ON THE METABOLIC EFFECTS OF DIAZOXIDE. Journal of Pharmacology and Experimental Therapeutics. 150(3). 455–462. 19 indexed citations
19.
Tabachnick, I.I.A., A. Gulbenkian, & FLOYD SEIDMAN. (1964). The Effect of a Benzothiadiazine, Diazoxide, on Carbohydrate Metabolism. Diabetes. 13(4). 408–418. 74 indexed citations
20.
Gulbenkian, A., et al.. (1961). Identification of a Compound found during Separation of Purines in Human Urine. Nature. 189(4765). 671–671. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026